NDC product
Zafirlukast
NDC 16571-655 · Rising Pharma Holdings, Inc.
Key facts
| Product NDC | 16571-655 |
|---|---|
| Proprietary name | Zafirlukast |
| Labeler | Rising Pharma Holdings, Inc. |
| Marketing category | ANDA |
| Application number | ANDA204928 |
| Marketing start | Aug 25, 2022 |
| Marketing end | Aug 26, 2022 |
| Listing certified through | Aug 26, 2022 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: